Funding for this research was provided by:
Regione Puglia (POR Puglia FESR-FSE 2014-2020 Innonetwork)
Received: 11 October 2022
Accepted: 8 November 2022
First Online: 18 November 2022
: The study that produced the data used for these analyses was conducted in accordance with the Declaration of Helsinki and approved by a local ethics committee in Italy, namely the Istituto Tumori Bari “Giovanni Paolo II” - IRCCS, with the protocol number n. 333 / C.E. of 31/07/2019. Informed consent to participate was obtained from the study participants. The team acquired the permission to access and analyze the clinical patient data by GPI S.p.A. through the Contract 210202009864 between GPI S.p.A. and FBK.
: GPI S.p.A. took part in the writing of the manuscript.